Screening devices and methods for obstructive sleep apnea therapy

Patent metadata

Field	Value
Publication number	US-9555247-B2
Application number	US-201514803779-A
Country	US
Kind code	B2
Filing date	Jul 20, 2015
Priority date	Jan 28, 2011
Publication date	Jan 31, 2017
Grant date	Jan 31, 2017

Abstract

Devices and methods for treating obstructive sleep apnea by first performing an assessment of the patient that involves observing the patient's upper airway during a tongue protrusion maneuver. The assessment may, for example, be done using endoscopy to observe the upper airway while the patient is awake in the supine position. An adequate response of the upper airway during the tongue protrusion maneuver is indicative of likely therapeutic success with hypoglossal nerve stimulation, and may be used for making clinical decisions. The principles of the present invention may be applied to other therapeutic interventions for OSA involving the upper airway.

First claim

What is claimed is:

1. A method of assessing a patient's suitability for an upper airway stimulation therapy, the method comprising:
inserting a visualization device into the patient's upper airway to evaluate a tissue linkage between the patient's genioglossus and at least one of the patient's soft palate and the patient's lateral pharyngeal walls;
documenting a degree of tissue redundancy in said tissue linkage; and
receiving a criterion, the criterion concerning the patient's suitability for the upper airway stimulation therapy.

2. The method of claim 1 , wherein the tissue linkage communicates a movement of the patient's genioglossus to a corresponding movement of the patient's soft palate and/or lateral pharyngeal walls.

3. The method of claim 1 , wherein the degree of tissue redundancy corresponds to a quantity of adipose tissue observed in the patient's soft palate and/or lateral pharyngeal walls.

4. The method of claim 1 , further comprising:
documenting the patient's body mass index (BMI).

5. The method of claim 4 , wherein the degree of tissue redundancy corresponds to a magnitude of the patient's BMI.

6. The method of claim 1 , further comprising:
protruding the patient's tongue without nerve stimulation while observing a response of the patient's airway with the visualization device.

7. The method of claim 1 , wherein the documenting of the degree of tissue redundancy takes place when the patient is subjected to drug-induced sleep endoscopy (OISE).

8. A method of assessing a patient's suitability for an upper airway stimulation therapy, the method comprising:
inserting a visualization device into the patient's upper airway to evaluate a tissue linkage between the patient's genioglossus and at least one of the patient's soft palate and the patient's lateral pharyngeal walls;
documenting a tissue redundancy presence in said tissue linkage; and
receiving a criterion, the criterion concerning the patient's suitability for the upper airway stimulation therapy.

9. The method of claim 8 , wherein the tissue linkage communicates a movement of the patient's genioglossus to a corresponding movement of the patient's soft palate and/or lateral pharyngeal walls.

10. The method of claim 8 , wherein the tissue redundancy presence corresponds to a quantity of adipose tissue observed in the patient's soft palate and/or lateral pharyngeal walls.

11. The method of claim 8 , further comprising:
documenting the patient's body mass index (BMI).

12. The method of claim 11 , wherein the tissue redundancy presence corresponds to a magnitude of the patient's BMI.

13. The method of claim 8 , further comprising:
protruding the patient's tongue without nerve stimulation while observing a response of the patient's airway with the visualization device.

14. The method of claim 8 , wherein the documenting of the tissue redundancy presence takes place when the patient is subjected to drug-induced sleep endoscopy (OISE).

15. A method of assessing a patient's suitability for an upper airway stimulation therapy, the method comprising:
recording with an imaging device at least a portion of a tissue linkage between the patient's genioglossus and at least one of the patient's soft palate and the patient's lateral pharyngeal walls;
recording a tissue redundancy exhibited by said tissue linkage; and
generating a record of said recordings, wherein the record includes a characterization of said tissue redundancy,
wherein the record is configured for comparison to a criterion, the criterion concerning the patient's suitability for the upper airway stimulation therapy.

16. The method of claim 15 , wherein the tissue linkage communicates a movement of the patient's genioglossus to a corresponding movement of the patient's soft palate and/or lateral pharyngeal walls.

17. The method of claim 15 , wherein the characterization of said tissue redundancy corresponds to a quantity of adipose tissue observed in the patient's soft palate and/or lateral pharyngeal walls.

18. The method of claim 15 , further comprising:
documenting the patient's body mass index (BMI).

19. The method of claim 18 , wherein the characterization of said tissue redundancy corresponds to a magnitude of the patient's BMI.

20. The method of claim 15 , further comprising:
protruding the patient's tongue without nerve stimulation while observing a response of the patient's airway with the imaging device.

21. The method of claim 15 , wherein the record is generated when the patient is subjected to drug-induced sleep endoscopy (OISE).

Assignees

• Cyberonics Inc

Inventors

• Tesfayesus Wondimeneh
• Bolea Stephen L
• Eastwood Peter R
• Hillman David R

Classifications

• A61B1/267

  for the respiratory tract, e.g. laryngoscopes, bronchoscopes · CPC title

• A61B1/233

  for the nose, i.e. nasoscopes {, e.g. testing of patency of Eustachian tubes} · CPC title

• A61N1/0519

  Endotracheal electrodes · CPC title

• A61N1/3611 Primary

  Respiration control (stimulating respiratory organs A61N1/3601) · CPC title

• A61N1/3601

  of respiratory organs · CPC title